Clinical Trials Directory

Trials / Unknown

UnknownNCT03402191

L-arginine Versus Sildenafil in Children With Beta Thalassemia Associated With Pulmonary Hypertension

Comparative Clinical Study Evaluating the Effect of L-arginine Versus Sildenafil in Children With Beta Thalassemia Associated With Pulmonary Hypertension

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Sherief Abd-Elsalam · Academic / Other
Sex
All
Age
6 Years – 18 Years
Healthy volunteers
Not accepted

Summary

This study compares L-arginine Versus Sildenafil as treatment for pulmonary hypertension in Children with Beta Thalassemia

Detailed description

This study focuses on different lines of treatment for pulmonary hypertension in children with thalassemia as this study discusses the Effect of L-arginine Versus Sildenafil in Children with Beta Thalassemia Associated with Pulmonary Hypertension

Conditions

Interventions

TypeNameDescription
DRUGL-argininel-arginine for thalassemia with pulmonary hypertension
DRUGSildenafilSildenafil for thalassemia with pulmonary hypertension

Timeline

Start date
2016-07-01
Primary completion
2023-12-01
Completion
2023-12-01
First posted
2018-01-18
Last updated
2018-08-27

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03402191. Inclusion in this directory is not an endorsement.